United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Sep 17, 2026 · Filed Sep 18, 2026

On Sep 17, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$496.06 for US$4.71M under a trading plan, leaving 324,443 shares. Filed Sep 18, 2026 (Form 4).

Sold
9,500 shares
Price
US$496.06 average (US$493.22 to US$501.60)
Value
US$4.71M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 17, 2026Common StockOption exercise9,500US$117.76333,943Indirect
Sep 17, 2026Common StockSale599US$493.22333,344Indirect
Sep 17, 2026Common StockSale1,750US$494.34331,594Indirect
Sep 17, 2026Common StockSale1,905US$495.11329,689Indirect
Sep 17, 2026Common StockSale2,182US$496.21327,507Indirect
Sep 17, 2026Common StockSale1,953US$497.17325,554Indirect
Sep 17, 2026Common StockSale151US$497.79325,403Indirect
Sep 17, 2026Common StockSale332US$499.10325,071Indirect
Sep 17, 2026Common StockSale468US$500.09324,603Indirect
Sep 17, 2026Common StockSale160US$501.60324,443Indirect

Source

View original at SEC

Related